SPHDF fundamentals
An in-depth look to Santhera Pharmaceuticals Holdings Ltd. operating, investing, and financing activities
SPHDF free cash flow for H1 24 is -17.08 M USD. For 2023, SPHDF free cash flow was 56.04 M USD and operating cash flow was 56.15 M USD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
TTM